Marissa Totten

Marissa Totten

Auto-generated profile, based on publicly available information

Marissa Totten

Divsion of Medical Microbiology, Department of Pathology and Division of Microbiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
BLBaoming Liu
Baoming Liu
MTMarissa Totten
Marissa Totten
SNSaman Nematollahi
Saman Nematollahi
KDKausik Datta
Kausik Datta
WMWarda Memon
Warda Memon
SZSean Zhang
Sean Zhang

18 February 2022 in ACS Infectious Diseases
Verified
Journal Article
Open access
CCCourtney E. Chandler
Courtney E. Chandler
FHFrancisco G. Hernandez
Francisco G. Hernandez
MTMarissa Totten
Marissa Totten
NRNatalie G. Robinett
Natalie G. Robinett
SSSabrina S. Schatzman
Sabrina S. Schatzman
VCValeria C. Culotta
Valeria C. Culotta
Candida auris is an emerging multidrug-resistant fungal pathogen. With high mortality rates, there is an urgent need for new antifungals to combat C. auris. Possible antifungal targets include Cu-only superoxide dismutases (SODs), extracellular SODs that are unique to fungi and effectively combat the superoxide burst of host immunity. Cu-only SODs are essential for the virulence of diverse fungal pathogens; however, little is understood about these enzymes in C. auris. We show here that C. auris secretes an enzymatically active Cu-only SOD (CaurSOD4) when cells are starved for Fe, a condition mimicking host environments. Although predicted to attach to cell walls, CaurSOD4 is detected as a soluble extracellular enzyme and can act at a distance to remove superoxide. CaurSOD4 selectively binds Cu and not Zn, and Cu binding is labile compared to bimetallic Cu/Zn SODs. Moreover, CaurSOD4 is susceptible to inhibition by various metal-binding drugs that are without effect on mammalian Cu/Zn SODs. Our studies highlight CaurSOD4 as a potential antifungal target worthy of consideration.